drugset / Trial / NCT00700583

Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men

NCT00700583

Completed 72 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

The aim of the present study was to determine whether the combined administration of a diuretic agent, hydrochlorothiazide, at night would improve the frequency of nocturia unresponsive to alpha-blocker monotherapy in men with LUTS.

Timeline

Start
2008-05
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 25 mg
Background Terazosin Small molecule 4 mg

Indications

No indication recorded.